American Cancer Society rally to reduce cancer burden

Cancer advocates rallied in Springfield this week to call on state lawmakers to improve access to colorectal cancer screenings and to support taxing other tobacco products at an equal rate to cigarettes.

Focused Ultrasound Matches Prostatectomy for Intermediate-Risk Prostate Cancer

LAS VEGAS — Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years of follow-up, treatment failure had occurred in 5.6% of patients treated with focused ablation and 7.9% of the prostatectomy groups. The difference did not achieve statistical […]

Immunotherapy/BCG Combo Boosts EFS in Non-Muscle Invasive Bladder Cancer

LAS VEGAS — Event-free survival (EFS) in high-risk non-muscle invasive bladder cancer (NMIBC) improved significantly when patients received the PD-1 inhibitor sasanlimab in addition to bacillus Calmette-Guérin (BCG), a randomized trial showed. The 3-year EFS increased from 74.8% with standard-of-care BCG induction and maintenance to 82.1% with the addition of sasanlimab. Most of the improvement […]

Unprecedented Response Rates in Non-Responsive, Non-Muscle Invasive Bladder Cancer

LAS VEGAS — Patients with high-risk, treatment-unresponsive non-muscle invasive bladder cancer (NMIBC) had an unprecedented response rate and disease-free survival (DFS) with an investigational intravesical treatment system, data from an ongoing trial showed. Complete responses (CR) occurred in 82.4% of 85 patients treated with TAR-200, a system that delivers gemcitabine directly into the bladder. The […]